Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1612.00
-61.55 (-3.68%)
< Home < Back

Sun Pharma’s arm acquires Uractiv Portfolio from Fiterman Pharma in Romania

Date: 27-05-2022

Sun Pharmaceutical Industries’ subsidiary -- S.C. Terapia S.A., Romania has acquired the Uractiv portfolio from Fiterman Pharma in Romania. The Uractiv portfolio comprises food supplements including minerals, vitamins and adjuvants; cosmetics and medical devices used for maintaining urinary tract health. 

Uractiv is the No. 1 brand in its category in Romania, trusted by consumers for more than 10 years. The portfolio including 12 SKUs has annualised revenues of approximately $8.7 million. The products cater to both adults and children. This acquisition is in line with company’s strategy to further expand its non-prescription product basket in Romania and neighbouring markets.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.